Doctors first discovered Maddie’s cancer when she was only four months old. They removed the golf ball-sized tumor and she subsequently had 12 rounds of chemotherapy. But the cancer returned and spread. There was no established cure in cases of relapse and her cancer proved resistant to three additional chemotherapy protocols.
Researchers believe that Maddie’s is the first CPC case in which a molecularly targeted therapy successfully overcame the cancer for a sustained period. Her story “highlights the importance of incorporating molecular guided therapy in treatment options for such cases,” the researchers wrote for an article published in Frontiers of Pharmacology.
Tracy calls Thermo Fisher’s NGS technology “our miracle.”
Now in fifth grade, Maddie is a quiet, thoughtful girl, who seems to be comfortable with solitude. She’s quick to give her mom a hug and declare her love, one sign Tracy said, that their bond is a little different than the bond the mother has with her other two children, Avah and Hunter.
Maddie experienced some learning issues and has trouble with short term memory, which doctors think is related to her illness, surgery and other treatments. She loves science, especially lessons about the moon and stars, and credits her fondness for the subject to her science teacher, her favorite. She’s also fond of Ladybug, the Jack Russell Terrier that is her support dog.
She advises the parents to push back, and be stubborn, just as she was when doctors said there was nothing more they could do.
“Don’t give up,” Tracy urges them. “Keep looking for alternatives. Give your doctor the information on Madison’s case.”